Sustained Viral Response Following Treatment With Direct-Acting Antiviral Regimens Is Durable in More Than 6600 Patients: Results of the Gilead Sustained Virologic Response Registry Study

Conference Reports for NATAP

The Liver Meeting
San Francisco
November 2018


Sustained Viral Response Following Treatment With Direct-Acting Antiviral Regimens Is Durable in More Than 6600 Patients: Results of the Gilead Sustained Virologic Response Registry Study

	Reported by Jules Levin AASLD 2018 Nov 9-12 Boston